nodes	percent_of_prediction	percent_of_DWPC	metapath
L-Arginine—NOS2—Dexamethasone—multiple sclerosis	0.52	1	CbGbCtD
L-Arginine—AZIN2—medulla oblongata—multiple sclerosis	0.00691	0.0522	CbGeAlD
L-Arginine—AZIN2—midbrain—multiple sclerosis	0.00631	0.0478	CbGeAlD
L-Arginine—AZIN2—spinal cord—multiple sclerosis	0.00616	0.0466	CbGeAlD
L-Arginine—SLC7A4—nervous system—multiple sclerosis	0.00541	0.0409	CbGeAlD
L-Arginine—Rash macular—Cladribine—multiple sclerosis	0.00534	0.0715	CcSEcCtD
L-Arginine—SLC7A4—central nervous system—multiple sclerosis	0.00521	0.0394	CbGeAlD
L-Arginine—ARG2—brainstem—multiple sclerosis	0.00516	0.039	CbGeAlD
L-Arginine—ARG2—retina—multiple sclerosis	0.00498	0.0377	CbGeAlD
L-Arginine—AZIN2—cerebellum—multiple sclerosis	0.00488	0.0369	CbGeAlD
L-Arginine—ASL—nervous system—multiple sclerosis	0.00482	0.0365	CbGeAlD
L-Arginine—ASL—central nervous system—multiple sclerosis	0.00464	0.0351	CbGeAlD
L-Arginine—ASL—cerebellum—multiple sclerosis	0.00454	0.0343	CbGeAlD
L-Arginine—SLC7A4—brain—multiple sclerosis	0.00414	0.0313	CbGeAlD
L-Arginine—AZIN2—brain—multiple sclerosis	0.00397	0.03	CbGeAlD
L-Arginine—ASL—brain—multiple sclerosis	0.00369	0.0279	CbGeAlD
L-Arginine—ARG2—medulla oblongata—multiple sclerosis	0.0036	0.0272	CbGeAlD
L-Arginine—ARG2—midbrain—multiple sclerosis	0.00329	0.0249	CbGeAlD
L-Arginine—ARG2—spinal cord—multiple sclerosis	0.00321	0.0243	CbGeAlD
L-Arginine—SLC7A1—nervous system—multiple sclerosis	0.00316	0.0239	CbGeAlD
L-Arginine—SLC7A1—central nervous system—multiple sclerosis	0.00304	0.023	CbGeAlD
L-Arginine—SLC7A1—cerebellum—multiple sclerosis	0.00298	0.0225	CbGeAlD
L-Arginine—ARG2—nervous system—multiple sclerosis	0.0027	0.0205	CbGeAlD
L-Arginine—ARG2—central nervous system—multiple sclerosis	0.0026	0.0197	CbGeAlD
L-Arginine—ARG2—cerebellum—multiple sclerosis	0.00254	0.0193	CbGeAlD
L-Arginine—ASS1—medulla oblongata—multiple sclerosis	0.00252	0.0191	CbGeAlD
L-Arginine—Extravasation—Cladribine—multiple sclerosis	0.00251	0.0336	CcSEcCtD
L-Arginine—Platelet count decreased—Mitoxantrone—multiple sclerosis	0.00242	0.0324	CcSEcCtD
L-Arginine—SLC7A1—brain—multiple sclerosis	0.00242	0.0183	CbGeAlD
L-Arginine—ASS1—midbrain—multiple sclerosis	0.00231	0.0174	CbGeAlD
L-Arginine—ASS1—spinal cord—multiple sclerosis	0.00225	0.017	CbGeAlD
L-Arginine—Injection site reaction—Cladribine—multiple sclerosis	0.00218	0.0292	CcSEcCtD
L-Arginine—ARG2—brain—multiple sclerosis	0.00207	0.0156	CbGeAlD
L-Arginine—Skin necrosis—Methotrexate—multiple sclerosis	0.00205	0.0275	CcSEcCtD
L-Arginine—ASS1—nervous system—multiple sclerosis	0.0019	0.0143	CbGeAlD
L-Arginine—NOS3—nervous system—multiple sclerosis	0.00189	0.0143	CbGeAlD
L-Arginine—Necrosis—Mitoxantrone—multiple sclerosis	0.00183	0.0246	CcSEcCtD
L-Arginine—ASS1—central nervous system—multiple sclerosis	0.00182	0.0138	CbGeAlD
L-Arginine—NOS3—central nervous system—multiple sclerosis	0.00182	0.0138	CbGeAlD
L-Arginine—Swelling—Cladribine—multiple sclerosis	0.0018	0.0241	CcSEcCtD
L-Arginine—ASS1—cerebellum—multiple sclerosis	0.00178	0.0135	CbGeAlD
L-Arginine—Extravasation—Mitoxantrone—multiple sclerosis	0.00165	0.0221	CcSEcCtD
L-Arginine—Lethargy—Cladribine—multiple sclerosis	0.00162	0.0217	CcSEcCtD
L-Arginine—SLC22A5—retina—multiple sclerosis	0.00147	0.0111	CbGeAlD
L-Arginine—ASS1—brain—multiple sclerosis	0.00145	0.011	CbGeAlD
L-Arginine—NOS3—brain—multiple sclerosis	0.00144	0.0109	CbGeAlD
L-Arginine—SLC22A4—spinal cord—multiple sclerosis	0.00143	0.0108	CbGeAlD
L-Arginine—Necrosis—Methylprednisolone—multiple sclerosis	0.00138	0.0185	CcSEcCtD
L-Arginine—SLC16A10—cerebellum—multiple sclerosis	0.00127	0.00964	CbGeAlD
L-Arginine—Necrosis—Betamethasone—multiple sclerosis	0.00126	0.0168	CcSEcCtD
L-Arginine—Necrosis—Dexamethasone—multiple sclerosis	0.00126	0.0168	CcSEcCtD
L-Arginine—Swelling—Mitoxantrone—multiple sclerosis	0.00118	0.0159	CcSEcCtD
L-Arginine—SLC22A4—cerebellum—multiple sclerosis	0.00113	0.00859	CbGeAlD
L-Arginine—Extravasation—Dexamethasone—multiple sclerosis	0.00113	0.0151	CcSEcCtD
L-Arginine—Extravasation—Betamethasone—multiple sclerosis	0.00113	0.0151	CcSEcCtD
L-Arginine—Necrosis—Prednisone—multiple sclerosis	0.00109	0.0147	CcSEcCtD
L-Arginine—SLC22A5—medulla oblongata—multiple sclerosis	0.00106	0.00804	CbGeAlD
L-Arginine—Skin exfoliation—Triamcinolone—multiple sclerosis	0.00104	0.0139	CcSEcCtD
L-Arginine—Skin exfoliation—Methylprednisolone—multiple sclerosis	0.00103	0.0139	CcSEcCtD
L-Arginine—SLC22A5—midbrain—multiple sclerosis	0.000971	0.00734	CbGeAlD
L-Arginine—SLC22A5—spinal cord—multiple sclerosis	0.000947	0.00717	CbGeAlD
L-Arginine—Skin exfoliation—Betamethasone—multiple sclerosis	0.000941	0.0126	CcSEcCtD
L-Arginine—Skin exfoliation—Dexamethasone—multiple sclerosis	0.000941	0.0126	CcSEcCtD
L-Arginine—SLC22A4—brain—multiple sclerosis	0.000922	0.00697	CbGeAlD
L-Arginine—Necrosis—Methotrexate—multiple sclerosis	0.000914	0.0122	CcSEcCtD
L-Arginine—Headache—Fingolimod—multiple sclerosis	0.000863	0.0116	CcSEcCtD
L-Arginine—Extravasation—Methotrexate—multiple sclerosis	0.000822	0.011	CcSEcCtD
L-Arginine—Skin exfoliation—Prednisone—multiple sclerosis	0.000819	0.011	CcSEcCtD
L-Arginine—Sweating—Mitoxantrone—multiple sclerosis	0.000772	0.0103	CcSEcCtD
L-Arginine—Haematuria—Mitoxantrone—multiple sclerosis	0.000768	0.0103	CcSEcCtD
L-Arginine—Tachycardia—Cladribine—multiple sclerosis	0.000763	0.0102	CcSEcCtD
L-Arginine—Hyperhidrosis—Cladribine—multiple sclerosis	0.000755	0.0101	CcSEcCtD
L-Arginine—SLC22A5—cerebellum—multiple sclerosis	0.000751	0.00568	CbGeAlD
L-Arginine—Anorexia—Cladribine—multiple sclerosis	0.000745	0.00998	CcSEcCtD
L-Arginine—Lethargy—Dexamethasone—multiple sclerosis	0.00073	0.00978	CcSEcCtD
L-Arginine—Lethargy—Betamethasone—multiple sclerosis	0.00073	0.00978	CcSEcCtD
L-Arginine—NOS2—Type II interferon signaling (IFNG)—IFNG—multiple sclerosis	0.0007	0.00256	CbGpPWpGaD
L-Arginine—NOS2—IL23-mediated signaling events—IFNG—multiple sclerosis	0.0007	0.00256	CbGpPWpGaD
L-Arginine—Skin exfoliation—Methotrexate—multiple sclerosis	0.000685	0.00918	CcSEcCtD
L-Arginine—ARG2—Metabolism—SRM—multiple sclerosis	0.000684	0.0025	CbGpPWpGaD
L-Arginine—Decreased appetite—Cladribine—multiple sclerosis	0.000679	0.0091	CcSEcCtD
L-Arginine—NOS2—IL23-mediated signaling events—CD4—multiple sclerosis	0.000676	0.00247	CbGpPWpGaD
L-Arginine—NOS3—SHP2 signaling—BDNF—multiple sclerosis	0.000676	0.00247	CbGpPWpGaD
L-Arginine—NOS2—Spinal Cord Injury—CCR2—multiple sclerosis	0.000661	0.00242	CbGpPWpGaD
L-Arginine—NOS3—EGF/EGFR Signaling Pathway—CBLB—multiple sclerosis	0.000654	0.00239	CbGpPWpGaD
L-Arginine—SLC7A1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000652	0.00238	CbGpPWpGaD
L-Arginine—NOS2—IL12-mediated signaling events—HLA-DRB1—multiple sclerosis	0.000651	0.00238	CbGpPWpGaD
L-Arginine—NOS3—Angiogenesis—MMP9—multiple sclerosis	0.000647	0.00236	CbGpPWpGaD
L-Arginine—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—multiple sclerosis	0.000646	0.00236	CbGpPWpGaD
L-Arginine—NOS3—Validated transcriptional targets of AP1 family members Fra1 and Fra2—CCL2—multiple sclerosis	0.00064	0.00234	CbGpPWpGaD
L-Arginine—AZIN2—Metabolism—CYP24A1—multiple sclerosis	0.000636	0.00232	CbGpPWpGaD
L-Arginine—AZIN2—Metabolism—CYP27B1—multiple sclerosis	0.000636	0.00232	CbGpPWpGaD
L-Arginine—Lethargy—Prednisone—multiple sclerosis	0.000636	0.00852	CcSEcCtD
L-Arginine—NOS2—Type II interferon signaling (IFNG)—IL1B—multiple sclerosis	0.000625	0.00228	CbGpPWpGaD
L-Arginine—NOS2—IL23-mediated signaling events—IL1B—multiple sclerosis	0.000625	0.00228	CbGpPWpGaD
L-Arginine—NOS2—IL23-mediated signaling events—IL2—multiple sclerosis	0.000622	0.00228	CbGpPWpGaD
L-Arginine—SLC22A5—brain—multiple sclerosis	0.00061	0.00461	CbGeAlD
L-Arginine—NOS2—Hemostasis—CD58—multiple sclerosis	0.000609	0.00223	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—SELPLG—multiple sclerosis	0.000609	0.00223	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—MERTK—multiple sclerosis	0.000609	0.00223	CbGpPWpGaD
L-Arginine—SLC7A3—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000606	0.00222	CbGpPWpGaD
L-Arginine—ASL—Metabolism—CYP27B1—multiple sclerosis	0.000581	0.00213	CbGpPWpGaD
L-Arginine—ASL—Metabolism—CYP24A1—multiple sclerosis	0.000581	0.00213	CbGpPWpGaD
L-Arginine—AZIN2—Metabolism—GPC5—multiple sclerosis	0.000581	0.00213	CbGpPWpGaD
L-Arginine—Sweating—Methylprednisolone—multiple sclerosis	0.000581	0.00779	CcSEcCtD
L-Arginine—Hypersensitivity—Cladribine—multiple sclerosis	0.000576	0.00771	CcSEcCtD
L-Arginine—NOS3—SHP2 signaling—IL2RA—multiple sclerosis	0.000575	0.0021	CbGpPWpGaD
L-Arginine—SLC22A4—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	0.000559	0.00204	CbGpPWpGaD
L-Arginine—SLC22A5—SLC-mediated transmembrane transport—SLC15A2—multiple sclerosis	0.000554	0.00203	CbGpPWpGaD
L-Arginine—SLC16A10—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	0.00055	0.00201	CbGpPWpGaD
L-Arginine—NOS2—Spinal Cord Injury—CXCL10—multiple sclerosis	0.000549	0.00201	CbGpPWpGaD
L-Arginine—ASL—Metabolism—GPC5—multiple sclerosis	0.000532	0.00194	CbGpPWpGaD
L-Arginine—Lethargy—Methotrexate—multiple sclerosis	0.000531	0.00712	CcSEcCtD
L-Arginine—NOS2—IL23-mediated signaling events—STAT3—multiple sclerosis	0.000524	0.00191	CbGpPWpGaD
L-Arginine—NOS3—Angiogenesis—MAPK1—multiple sclerosis	0.000523	0.00191	CbGpPWpGaD
L-Arginine—SLC7A1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	0.000515	0.00188	CbGpPWpGaD
L-Arginine—Anaphylactic shock—Mitoxantrone—multiple sclerosis	0.000514	0.00688	CcSEcCtD
L-Arginine—NOS3—Thromboxane A2 receptor signaling—ICAM1—multiple sclerosis	0.000513	0.00188	CbGpPWpGaD
L-Arginine—NOS2—IL12-mediated signaling events—TYK2—multiple sclerosis	0.000508	0.00186	CbGpPWpGaD
L-Arginine—Tachycardia—Mitoxantrone—multiple sclerosis	0.000501	0.00672	CcSEcCtD
L-Arginine—Vomiting—Cladribine—multiple sclerosis	0.000497	0.00666	CcSEcCtD
L-Arginine—Hyperhidrosis—Mitoxantrone—multiple sclerosis	0.000496	0.00665	CcSEcCtD
L-Arginine—NOS2—Spinal Cord Injury—BDNF—multiple sclerosis	0.000493	0.0018	CbGpPWpGaD
L-Arginine—Rash—Cladribine—multiple sclerosis	0.000493	0.0066	CcSEcCtD
L-Arginine—Dermatitis—Cladribine—multiple sclerosis	0.000492	0.0066	CcSEcCtD
L-Arginine—Anorexia—Mitoxantrone—multiple sclerosis	0.00049	0.00656	CcSEcCtD
L-Arginine—Headache—Cladribine—multiple sclerosis	0.000489	0.00656	CcSEcCtD
L-Arginine—NOS2—ATF-2 transcription factor network—IFNG—multiple sclerosis	0.000482	0.00176	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—CYP24A1—multiple sclerosis	0.000482	0.00176	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—CYP27B1—multiple sclerosis	0.000482	0.00176	CbGpPWpGaD
L-Arginine—AZIN2—Metabolism—RRM1—multiple sclerosis	0.000482	0.00176	CbGpPWpGaD
L-Arginine—SLC7A3—Transmembrane transport of small molecules—AQP4—multiple sclerosis	0.000479	0.00175	CbGpPWpGaD
L-Arginine—NOS2—IL12-mediated signaling events—IFNG—multiple sclerosis	0.000476	0.00174	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—SRM—multiple sclerosis	0.000474	0.00173	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—SELPLG—multiple sclerosis	0.000473	0.00173	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—MERTK—multiple sclerosis	0.000473	0.00173	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—CD58—multiple sclerosis	0.000473	0.00173	CbGpPWpGaD
L-Arginine—Hypersensitivity—Azathioprine—multiple sclerosis	0.000468	0.00627	CcSEcCtD
L-Arginine—Nausea—Cladribine—multiple sclerosis	0.000464	0.00622	CcSEcCtD
L-Arginine—NOS2—IL12-mediated signaling events—CD4—multiple sclerosis	0.000459	0.00168	CbGpPWpGaD
L-Arginine—NOS2—Spinal Cord Injury—IL4—multiple sclerosis	0.000458	0.00167	CbGpPWpGaD
L-Arginine—NOS3—Validated transcriptional targets of AP1 family members Fra1 and Fra2—MMP9—multiple sclerosis	0.000457	0.00167	CbGpPWpGaD
L-Arginine—SLC7A1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	0.000456	0.00167	CbGpPWpGaD
L-Arginine—NOS2—IL23-mediated signaling events—TNF—multiple sclerosis	0.000453	0.00166	CbGpPWpGaD
L-Arginine—NOS3—VEGFR1 specific signals—MAPK1—multiple sclerosis	0.000449	0.00164	CbGpPWpGaD
L-Arginine—Decreased appetite—Mitoxantrone—multiple sclerosis	0.000446	0.00598	CcSEcCtD
L-Arginine—ASL—Metabolism—RRM1—multiple sclerosis	0.000441	0.00161	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—GPC5—multiple sclerosis	0.000441	0.00161	CbGpPWpGaD
L-Arginine—NOS2—IL12-mediated signaling events—IL1B—multiple sclerosis	0.000424	0.00155	CbGpPWpGaD
L-Arginine—SLC7A3—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	0.000424	0.00155	CbGpPWpGaD
L-Arginine—NOS2—IL12-mediated signaling events—IL2—multiple sclerosis	0.000423	0.00155	CbGpPWpGaD
L-Arginine—Anaphylactic shock—Prednisolone—multiple sclerosis	0.000421	0.00565	CcSEcCtD
L-Arginine—NOS3—Plasma membrane estrogen receptor signaling—MMP9—multiple sclerosis	0.000421	0.00154	CbGpPWpGaD
L-Arginine—SLC22A5—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	0.00042	0.00153	CbGpPWpGaD
L-Arginine—Tachycardia—Prednisolone—multiple sclerosis	0.000411	0.00551	CcSEcCtD
L-Arginine—Hyperhidrosis—Prednisolone—multiple sclerosis	0.000407	0.00546	CcSEcCtD
L-Arginine—NOS3—Endothelin Pathways—MAPK1—multiple sclerosis	0.000405	0.00148	CbGpPWpGaD
L-Arginine—Vomiting—Azathioprine—multiple sclerosis	0.000404	0.00541	CcSEcCtD
L-Arginine—Rash—Azathioprine—multiple sclerosis	0.000401	0.00537	CcSEcCtD
L-Arginine—Dermatitis—Azathioprine—multiple sclerosis	0.0004	0.00536	CcSEcCtD
L-Arginine—Flushing—Prednisone—multiple sclerosis	0.0004	0.00536	CcSEcCtD
L-Arginine—Headache—Azathioprine—multiple sclerosis	0.000398	0.00533	CcSEcCtD
L-Arginine—SLC22A4—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	0.00039	0.00143	CbGpPWpGaD
L-Arginine—Anaphylactic shock—Triamcinolone—multiple sclerosis	0.000387	0.00519	CcSEcCtD
L-Arginine—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.000387	0.00518	CcSEcCtD
L-Arginine—Sweating—Methotrexate—multiple sclerosis	0.000385	0.00515	CcSEcCtD
L-Arginine—SLC16A10—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	0.000384	0.0014	CbGpPWpGaD
L-Arginine—Haematuria—Methotrexate—multiple sclerosis	0.000383	0.00513	CcSEcCtD
L-Arginine—NOS2—Spinal Cord Injury—TLR4—multiple sclerosis	0.00038	0.00139	CbGpPWpGaD
L-Arginine—NOS3—SHP2 signaling—IFNG—multiple sclerosis	0.00038	0.00139	CbGpPWpGaD
L-Arginine—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000378	0.00507	CcSEcCtD
L-Arginine—Tachycardia—Triamcinolone—multiple sclerosis	0.000378	0.00507	CcSEcCtD
L-Arginine—Nausea—Azathioprine—multiple sclerosis	0.000377	0.00506	CcSEcCtD
L-Arginine—Tachycardia—Methylprednisolone—multiple sclerosis	0.000377	0.00506	CcSEcCtD
L-Arginine—NOS2—Hemostasis—PLEK—multiple sclerosis	0.000376	0.00138	CbGpPWpGaD
L-Arginine—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000375	0.00502	CcSEcCtD
L-Arginine—SLC22A4—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000375	0.00137	CbGpPWpGaD
L-Arginine—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000374	0.00501	CcSEcCtD
L-Arginine—NOS2—AGE/RAGE pathway—MMP9—multiple sclerosis	0.000371	0.00136	CbGpPWpGaD
L-Arginine—SLC16A10—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000368	0.00135	CbGpPWpGaD
L-Arginine—NOS2—IL23-mediated signaling events—IL6—multiple sclerosis	0.000366	0.00134	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—RRM1—multiple sclerosis	0.000365	0.00133	CbGpPWpGaD
L-Arginine—NOS2—Spinal Cord Injury—ICAM1—multiple sclerosis	0.000364	0.00133	CbGpPWpGaD
L-Arginine—NOS3—Corticotropin-releasing hormone—TLR4—multiple sclerosis	0.00036	0.00131	CbGpPWpGaD
L-Arginine—NOS2—IL12-mediated signaling events—STAT3—multiple sclerosis	0.000356	0.0013	CbGpPWpGaD
L-Arginine—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.000352	0.00471	CcSEcCtD
L-Arginine—Anaphylactic shock—Betamethasone—multiple sclerosis	0.000352	0.00471	CcSEcCtD
L-Arginine—Tachycardia—Betamethasone—multiple sclerosis	0.000343	0.0046	CcSEcCtD
L-Arginine—Tachycardia—Dexamethasone—multiple sclerosis	0.000343	0.0046	CcSEcCtD
L-Arginine—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.00034	0.00455	CcSEcCtD
L-Arginine—Hyperhidrosis—Betamethasone—multiple sclerosis	0.00034	0.00455	CcSEcCtD
L-Arginine—NOS3—SHP2 signaling—IL2—multiple sclerosis	0.000337	0.00123	CbGpPWpGaD
L-Arginine—Anorexia—Betamethasone—multiple sclerosis	0.000335	0.00449	CcSEcCtD
L-Arginine—Anorexia—Dexamethasone—multiple sclerosis	0.000335	0.00449	CcSEcCtD
L-Arginine—ASS1—Metabolism—CYP24A1—multiple sclerosis	0.000334	0.00122	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—CYP27B1—multiple sclerosis	0.000334	0.00122	CbGpPWpGaD
L-Arginine—NOS2—AGE/RAGE pathway—STAT3—multiple sclerosis	0.00033	0.0012	CbGpPWpGaD
L-Arginine—NOS2—ATF-2 transcription factor network—MAPK1—multiple sclerosis	0.000328	0.0012	CbGpPWpGaD
L-Arginine—Vomiting—Mitoxantrone—multiple sclerosis	0.000327	0.00438	CcSEcCtD
L-Arginine—NOS2—Spinal Cord Injury—CCL2—multiple sclerosis	0.000326	0.00119	CbGpPWpGaD
L-Arginine—NOS2—Rac1/Pak1/p38/MMP-2 pathway—STAT3—multiple sclerosis	0.000326	0.00119	CbGpPWpGaD
L-Arginine—Rash—Mitoxantrone—multiple sclerosis	0.000324	0.00434	CcSEcCtD
L-Arginine—Dermatitis—Mitoxantrone—multiple sclerosis	0.000324	0.00434	CcSEcCtD
L-Arginine—SLC7A1—SLC-mediated transmembrane transport—ALB—multiple sclerosis	0.000323	0.00118	CbGpPWpGaD
L-Arginine—Headache—Mitoxantrone—multiple sclerosis	0.000322	0.00431	CcSEcCtD
L-Arginine—NOS3—Corticotropin-releasing hormone—POMC—multiple sclerosis	0.000315	0.00115	CbGpPWpGaD
L-Arginine—Hypersensitivity—Prednisolone—multiple sclerosis	0.00031	0.00416	CcSEcCtD
L-Arginine—Anaphylactic shock—Prednisone—multiple sclerosis	0.000306	0.0041	CcSEcCtD
L-Arginine—Decreased appetite—Dexamethasone—multiple sclerosis	0.000306	0.0041	CcSEcCtD
L-Arginine—Decreased appetite—Betamethasone—multiple sclerosis	0.000306	0.0041	CcSEcCtD
L-Arginine—ASS1—Metabolism—GPC5—multiple sclerosis	0.000305	0.00112	CbGpPWpGaD
L-Arginine—Nausea—Mitoxantrone—multiple sclerosis	0.000305	0.00409	CcSEcCtD
L-Arginine—NOS2—Rac1/Pak1/p38/MMP-2 pathway—MYC—multiple sclerosis	0.000303	0.00111	CbGpPWpGaD
L-Arginine—SLC7A3—SLC-mediated transmembrane transport—ALB—multiple sclerosis	0.0003	0.0011	CbGpPWpGaD
L-Arginine—NOS2—AGE/RAGE pathway—MAPK1—multiple sclerosis	0.0003	0.0011	CbGpPWpGaD
L-Arginine—Tachycardia—Prednisone—multiple sclerosis	0.000299	0.004	CcSEcCtD
L-Arginine—NOS2—Rac1/Pak1/p38/MMP-2 pathway—MAPK1—multiple sclerosis	0.000296	0.00108	CbGpPWpGaD
L-Arginine—Hyperhidrosis—Prednisone—multiple sclerosis	0.000296	0.00397	CcSEcCtD
L-Arginine—SLC22A5—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	0.000293	0.00107	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—PLEK—multiple sclerosis	0.000292	0.00107	CbGpPWpGaD
L-Arginine—Anorexia—Prednisone—multiple sclerosis	0.000292	0.00391	CcSEcCtD
L-Arginine—NOS3—Angiopoietin receptor Tie2-mediated signaling—MAPK1—multiple sclerosis	0.000291	0.00106	CbGpPWpGaD
L-Arginine—NOS3—AGE/RAGE pathway—MMP9—multiple sclerosis	0.000288	0.00105	CbGpPWpGaD
L-Arginine—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000285	0.00383	CcSEcCtD
L-Arginine—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000285	0.00382	CcSEcCtD
L-Arginine—NOS3—Validated transcriptional targets of AP1 family members Fra1 and Fra2—IL6—multiple sclerosis	0.000284	0.00104	CbGpPWpGaD
L-Arginine—SLC22A4—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000284	0.00104	CbGpPWpGaD
L-Arginine—SLC22A5—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000282	0.00103	CbGpPWpGaD
L-Arginine—SLC16A10—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000279	0.00102	CbGpPWpGaD
L-Arginine—NOS2—Spinal Cord Injury—IFNG—multiple sclerosis	0.000277	0.00101	CbGpPWpGaD
L-Arginine—AZIN2—Metabolism—BCHE—multiple sclerosis	0.000277	0.00101	CbGpPWpGaD
L-Arginine—NOS3—Angiopoietin receptor Tie2-mediated signaling—TNF—multiple sclerosis	0.000277	0.00101	CbGpPWpGaD
L-Arginine—NOS2—Circadian rythm related genes—FAS—multiple sclerosis	0.000276	0.00101	CbGpPWpGaD
L-Arginine—NOS3—Leptin signaling pathway—IL1B—multiple sclerosis	0.000276	0.00101	CbGpPWpGaD
L-Arginine—Decreased appetite—Prednisone—multiple sclerosis	0.000266	0.00357	CcSEcCtD
L-Arginine—Rash—Prednisolone—multiple sclerosis	0.000266	0.00356	CcSEcCtD
L-Arginine—Dermatitis—Prednisolone—multiple sclerosis	0.000265	0.00356	CcSEcCtD
L-Arginine—NOS2—Hemostasis—SELE—multiple sclerosis	0.000265	0.000969	CbGpPWpGaD
L-Arginine—Headache—Prednisolone—multiple sclerosis	0.000264	0.00354	CcSEcCtD
L-Arginine—NOS3—AGE/RAGE pathway—STAT3—multiple sclerosis	0.000256	0.000936	CbGpPWpGaD
L-Arginine—Anaphylactic shock—Methotrexate—multiple sclerosis	0.000256	0.00343	CcSEcCtD
L-Arginine—ASL—Metabolism—BCHE—multiple sclerosis	0.000253	0.000925	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—RRM1—multiple sclerosis	0.000253	0.000925	CbGpPWpGaD
L-Arginine—NOS2—ATF-2 transcription factor network—IL6—multiple sclerosis	0.000252	0.000921	CbGpPWpGaD
L-Arginine—Nausea—Prednisolone—multiple sclerosis	0.00025	0.00335	CcSEcCtD
L-Arginine—NOS3—VEGFA-VEGFR2 Pathway—TYK2—multiple sclerosis	0.000248	0.000908	CbGpPWpGaD
L-Arginine—Hyperhidrosis—Methotrexate—multiple sclerosis	0.000247	0.00331	CcSEcCtD
L-Arginine—NOS2—Spinal Cord Injury—IL1B—multiple sclerosis	0.000247	0.000903	CbGpPWpGaD
L-Arginine—Vomiting—Triamcinolone—multiple sclerosis	0.000246	0.0033	CcSEcCtD
L-Arginine—NOS2—Spinal Cord Injury—IL2—multiple sclerosis	0.000246	0.0009	CbGpPWpGaD
L-Arginine—Vomiting—Methylprednisolone—multiple sclerosis	0.000246	0.00329	CcSEcCtD
L-Arginine—Rash—Triamcinolone—multiple sclerosis	0.000244	0.00327	CcSEcCtD
L-Arginine—Dermatitis—Triamcinolone—multiple sclerosis	0.000244	0.00327	CcSEcCtD
L-Arginine—Anorexia—Methotrexate—multiple sclerosis	0.000244	0.00327	CcSEcCtD
L-Arginine—Rash—Methylprednisolone—multiple sclerosis	0.000244	0.00327	CcSEcCtD
L-Arginine—Dermatitis—Methylprednisolone—multiple sclerosis	0.000244	0.00326	CcSEcCtD
L-Arginine—Headache—Triamcinolone—multiple sclerosis	0.000243	0.00325	CcSEcCtD
L-Arginine—Headache—Methylprednisolone—multiple sclerosis	0.000242	0.00325	CcSEcCtD
L-Arginine—NOS3—Signaling by VEGF—TYK2—multiple sclerosis	0.000234	0.000857	CbGpPWpGaD
L-Arginine—NOS3—Corticotropin-releasing hormone—IL2—multiple sclerosis	0.000233	0.000852	CbGpPWpGaD
L-Arginine—NOS2—Spinal Cord Injury—MMP9—multiple sclerosis	0.000233	0.000851	CbGpPWpGaD
L-Arginine—NOS3—AGE/RAGE pathway—MAPK1—multiple sclerosis	0.000233	0.00085	CbGpPWpGaD
L-Arginine—NOS3—Leptin signaling pathway—STAT3—multiple sclerosis	0.000231	0.000845	CbGpPWpGaD
L-Arginine—Nausea—Triamcinolone—multiple sclerosis	0.00023	0.00308	CcSEcCtD
L-Arginine—Nausea—Methylprednisolone—multiple sclerosis	0.00023	0.00308	CcSEcCtD
L-Arginine—NOS3—Signaling events mediated by VEGFR1 and VEGFR2—MAPK1—multiple sclerosis	0.000227	0.00083	CbGpPWpGaD
L-Arginine—Hypersensitivity—Prednisone—multiple sclerosis	0.000226	0.00302	CcSEcCtD
L-Arginine—SLC22A4—Transmembrane transport of small molecules—AQP4—multiple sclerosis	0.000224	0.00082	CbGpPWpGaD
L-Arginine—Vomiting—Dexamethasone—multiple sclerosis	0.000224	0.003	CcSEcCtD
L-Arginine—Vomiting—Betamethasone—multiple sclerosis	0.000224	0.003	CcSEcCtD
L-Arginine—Decreased appetite—Methotrexate—multiple sclerosis	0.000222	0.00298	CcSEcCtD
L-Arginine—Rash—Dexamethasone—multiple sclerosis	0.000222	0.00297	CcSEcCtD
L-Arginine—Rash—Betamethasone—multiple sclerosis	0.000222	0.00297	CcSEcCtD
L-Arginine—Dermatitis—Betamethasone—multiple sclerosis	0.000221	0.00297	CcSEcCtD
L-Arginine—Dermatitis—Dexamethasone—multiple sclerosis	0.000221	0.00297	CcSEcCtD
L-Arginine—SLC16A10—Transmembrane transport of small molecules—AQP4—multiple sclerosis	0.000221	0.000807	CbGpPWpGaD
L-Arginine—Headache—Betamethasone—multiple sclerosis	0.00022	0.00295	CcSEcCtD
L-Arginine—Headache—Dexamethasone—multiple sclerosis	0.00022	0.00295	CcSEcCtD
L-Arginine—SLC22A5—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000213	0.00078	CbGpPWpGaD
L-Arginine—NOS3—Leptin signaling pathway—MAPK1—multiple sclerosis	0.00021	0.000768	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—BCHE—multiple sclerosis	0.00021	0.000767	CbGpPWpGaD
L-Arginine—Nausea—Dexamethasone—multiple sclerosis	0.000209	0.0028	CcSEcCtD
L-Arginine—Nausea—Betamethasone—multiple sclerosis	0.000209	0.0028	CcSEcCtD
L-Arginine—NOS3—Metabolism—SRM—multiple sclerosis	0.000206	0.000754	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—SELE—multiple sclerosis	0.000206	0.000753	CbGpPWpGaD
L-Arginine—NOS2—Disease—GPC5—multiple sclerosis	0.000204	0.000747	CbGpPWpGaD
L-Arginine—SLC22A4—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	0.000198	0.000725	CbGpPWpGaD
L-Arginine—NOS3—SHP2 signaling—IL6—multiple sclerosis	0.000198	0.000725	CbGpPWpGaD
L-Arginine—SLC16A10—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	0.000195	0.000713	CbGpPWpGaD
L-Arginine—Vomiting—Prednisone—multiple sclerosis	0.000195	0.00261	CcSEcCtD
L-Arginine—Rash—Prednisone—multiple sclerosis	0.000193	0.00259	CcSEcCtD
L-Arginine—Dermatitis—Prednisone—multiple sclerosis	0.000193	0.00258	CcSEcCtD
L-Arginine—NOS2—Spinal Cord Injury—MYC—multiple sclerosis	0.000192	0.000703	CbGpPWpGaD
L-Arginine—NOS2—Spinal Cord Injury—TGFB1—multiple sclerosis	0.000192	0.000702	CbGpPWpGaD
L-Arginine—Headache—Prednisone—multiple sclerosis	0.000192	0.00257	CcSEcCtD
L-Arginine—NOS2—Hemostasis—ITGA4—multiple sclerosis	0.000192	0.000701	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—IFNB1—multiple sclerosis	0.00019	0.000696	CbGpPWpGaD
L-Arginine—Hypersensitivity—Methotrexate—multiple sclerosis	0.000189	0.00253	CcSEcCtD
L-Arginine—NOS2—Spinal Cord Injury—MAPK1—multiple sclerosis	0.000188	0.000688	CbGpPWpGaD
L-Arginine—NOS3—Corticotropin-releasing hormone—TGFB1—multiple sclerosis	0.000182	0.000665	CbGpPWpGaD
L-Arginine—Nausea—Prednisone—multiple sclerosis	0.000182	0.00244	CcSEcCtD
L-Arginine—NOS2—Spinal Cord Injury—TNF—multiple sclerosis	0.000179	0.000655	CbGpPWpGaD
L-Arginine—NOS3—Corticotropin-releasing hormone—MAPK1—multiple sclerosis	0.000178	0.000652	CbGpPWpGaD
L-Arginine—SLC22A5—Transmembrane transport of small molecules—AQP4—multiple sclerosis	0.000169	0.000616	CbGpPWpGaD
L-Arginine—AZIN2—Metabolism—APOE—multiple sclerosis	0.000166	0.000609	CbGpPWpGaD
L-Arginine—SLC7A1—Transmembrane transport of small molecules—ALB—multiple sclerosis	0.000164	0.0006	CbGpPWpGaD
L-Arginine—Vomiting—Methotrexate—multiple sclerosis	0.000163	0.00218	CcSEcCtD
L-Arginine—Rash—Methotrexate—multiple sclerosis	0.000161	0.00216	CcSEcCtD
L-Arginine—Dermatitis—Methotrexate—multiple sclerosis	0.000161	0.00216	CcSEcCtD
L-Arginine—Headache—Methotrexate—multiple sclerosis	0.00016	0.00215	CcSEcCtD
L-Arginine—NOS3—Disease—GPC5—multiple sclerosis	0.000159	0.00058	CbGpPWpGaD
L-Arginine—NOS3—VEGFA-VEGFR2 Pathway—MAPK1—multiple sclerosis	0.000158	0.000578	CbGpPWpGaD
L-Arginine—NOS3—Myometrial Relaxation and Contraction Pathways—IL1B—multiple sclerosis	0.000154	0.000564	CbGpPWpGaD
L-Arginine—SLC7A3—Transmembrane transport of small molecules—ALB—multiple sclerosis	0.000153	0.000558	CbGpPWpGaD
L-Arginine—ASL—Metabolism—APOE—multiple sclerosis	0.000152	0.000557	CbGpPWpGaD
L-Arginine—Nausea—Methotrexate—multiple sclerosis	0.000152	0.00204	CcSEcCtD
L-Arginine—NOS3—Signaling Pathways—LINGO1—multiple sclerosis	0.000151	0.000551	CbGpPWpGaD
L-Arginine—NOS3—Signaling by VEGF—MAPK1—multiple sclerosis	0.000149	0.000545	CbGpPWpGaD
L-Arginine—SLC22A5—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	0.000149	0.000545	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—ITGA4—multiple sclerosis	0.000149	0.000544	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—IFNB1—multiple sclerosis	0.000148	0.00054	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—BCHE—multiple sclerosis	0.000145	0.000531	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—CYP27B1—multiple sclerosis	0.000145	0.000531	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—CYP24A1—multiple sclerosis	0.000145	0.000531	CbGpPWpGaD
L-Arginine—NOS2—Spinal Cord Injury—IL6—multiple sclerosis	0.000145	0.000529	CbGpPWpGaD
L-Arginine—AZIN2—Metabolism—POMC—multiple sclerosis	0.000143	0.000523	CbGpPWpGaD
L-Arginine—SLC22A4—SLC-mediated transmembrane transport—ALB—multiple sclerosis	0.000141	0.000514	CbGpPWpGaD
L-Arginine—SLC16A10—SLC-mediated transmembrane transport—ALB—multiple sclerosis	0.000138	0.000505	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—GPC5—multiple sclerosis	0.000133	0.000486	CbGpPWpGaD
L-Arginine—NOS2—Disease—RPL5—multiple sclerosis	0.000133	0.000486	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—IL2RA—multiple sclerosis	0.000131	0.000479	CbGpPWpGaD
L-Arginine—ASL—Metabolism—POMC—multiple sclerosis	0.000131	0.000478	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—TAGAP—multiple sclerosis	0.000131	0.000478	CbGpPWpGaD
L-Arginine—AZIN2—Metabolism—ALB—multiple sclerosis	0.00013	0.000477	CbGpPWpGaD
L-Arginine—NOS2—Disease—SLC11A1—multiple sclerosis	0.000127	0.000465	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—APOE—multiple sclerosis	0.000126	0.000461	CbGpPWpGaD
L-Arginine—NOS3—EGF/EGFR Signaling Pathway—STAT3—multiple sclerosis	0.000125	0.000456	CbGpPWpGaD
L-Arginine—NOS3—VEGFA-VEGFR2 Pathway—IL6—multiple sclerosis	0.000121	0.000444	CbGpPWpGaD
L-Arginine—ASL—Metabolism—ALB—multiple sclerosis	0.000119	0.000436	CbGpPWpGaD
L-Arginine—NOS3—Signaling by VEGF—IL6—multiple sclerosis	0.000115	0.000419	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—S1PR1—multiple sclerosis	0.000114	0.000418	CbGpPWpGaD
L-Arginine—NOS3—EGF/EGFR Signaling Pathway—MAPK1—multiple sclerosis	0.000113	0.000415	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—GPC5—multiple sclerosis	0.000111	0.000406	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—RRM1—multiple sclerosis	0.00011	0.000403	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—POMC—multiple sclerosis	0.000108	0.000396	CbGpPWpGaD
L-Arginine—SLC22A5—SLC-mediated transmembrane transport—ALB—multiple sclerosis	0.000106	0.000386	CbGpPWpGaD
L-Arginine—NOS3—Disease—RPL5—multiple sclerosis	0.000103	0.000377	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—IL2RA—multiple sclerosis	0.000102	0.000372	CbGpPWpGaD
L-Arginine—NOS2—Disease—CD28—multiple sclerosis	0.000102	0.000372	CbGpPWpGaD
L-Arginine—NOS3—Disease—SLC11A1—multiple sclerosis	9.89e-05	0.000361	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—ALB—multiple sclerosis	9.88e-05	0.000361	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—RGS1—multiple sclerosis	9.72e-05	0.000355	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—ALB—multiple sclerosis	9.47e-05	0.000346	CbGpPWpGaD
L-Arginine—NOS2—Circadian rythm related genes—IL6—multiple sclerosis	9.45e-05	0.000345	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—GPR65—multiple sclerosis	9.21e-05	0.000337	CbGpPWpGaD
L-Arginine—NOS3—Myometrial Relaxation and Contraction Pathways—IL6—multiple sclerosis	9.03e-05	0.00033	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—APOE—multiple sclerosis	8.74e-05	0.00032	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CCR1—multiple sclerosis	8.42e-05	0.000308	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CXCL13—multiple sclerosis	8.42e-05	0.000308	CbGpPWpGaD
L-Arginine—NOS3—Disease—CD28—multiple sclerosis	7.89e-05	0.000289	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—IL2—multiple sclerosis	7.68e-05	0.000281	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—POMC—multiple sclerosis	7.51e-05	0.000275	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—ALB—multiple sclerosis	7.35e-05	0.000269	CbGpPWpGaD
L-Arginine—NOS2—Disease—CD86—multiple sclerosis	7.25e-05	0.000265	CbGpPWpGaD
L-Arginine—SLC22A4—Transmembrane transport of small molecules—ALB—multiple sclerosis	7.14e-05	0.000261	CbGpPWpGaD
L-Arginine—SLC16A10—Transmembrane transport of small molecules—ALB—multiple sclerosis	7.03e-05	0.000257	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—ALB—multiple sclerosis	6.85e-05	0.00025	CbGpPWpGaD
L-Arginine—NOS2—Disease—CCR5—multiple sclerosis	6.43e-05	0.000235	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—BCHE—multiple sclerosis	6.33e-05	0.000231	CbGpPWpGaD
L-Arginine—NOS2—Disease—HLA-A—multiple sclerosis	6.27e-05	0.000229	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CCL3—multiple sclerosis	6e-05	0.000219	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—TGFB1—multiple sclerosis	5.99e-05	0.000219	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—IL2—multiple sclerosis	5.96e-05	0.000218	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—MAPK1—multiple sclerosis	5.87e-05	0.000215	CbGpPWpGaD
L-Arginine—NOS2—Disease—APOE—multiple sclerosis	5.85e-05	0.000214	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—PTGER4—multiple sclerosis	5.78e-05	0.000211	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—PGR—multiple sclerosis	5.69e-05	0.000208	CbGpPWpGaD
L-Arginine—NOS3—Disease—CD86—multiple sclerosis	5.63e-05	0.000206	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CXCR3—multiple sclerosis	5.58e-05	0.000204	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CD28—multiple sclerosis	5.53e-05	0.000202	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CCR2—multiple sclerosis	5.43e-05	0.000198	CbGpPWpGaD
L-Arginine—SLC22A5—Transmembrane transport of small molecules—ALB—multiple sclerosis	5.37e-05	0.000196	CbGpPWpGaD
L-Arginine—NOS2—Disease—CD80—multiple sclerosis	5.29e-05	0.000193	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CNR1—multiple sclerosis	5.01e-05	0.000183	CbGpPWpGaD
L-Arginine—NOS3—Disease—CCR5—multiple sclerosis	5e-05	0.000183	CbGpPWpGaD
L-Arginine—NOS3—Disease—HLA-A—multiple sclerosis	4.87e-05	0.000178	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—TGFB1—multiple sclerosis	4.65e-05	0.00017	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—MAPK1—multiple sclerosis	4.56e-05	0.000167	CbGpPWpGaD
L-Arginine—NOS3—Disease—APOE—multiple sclerosis	4.55e-05	0.000166	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CXCL10—multiple sclerosis	4.51e-05	0.000165	CbGpPWpGaD
L-Arginine—NOS2—Disease—TYK2—multiple sclerosis	4.47e-05	0.000163	CbGpPWpGaD
L-Arginine—NOS3—Disease—CD80—multiple sclerosis	4.11e-05	0.00015	CbGpPWpGaD
L-Arginine—NOS2—Disease—CD4—multiple sclerosis	4.04e-05	0.000148	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CD86—multiple sclerosis	3.94e-05	0.000144	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CCL5—multiple sclerosis	3.88e-05	0.000142	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—APOE—multiple sclerosis	3.81e-05	0.000139	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—SPP1—multiple sclerosis	3.6e-05	0.000131	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CCR5—multiple sclerosis	3.5e-05	0.000128	CbGpPWpGaD
L-Arginine—NOS3—Disease—TYK2—multiple sclerosis	3.47e-05	0.000127	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—IL2RA—multiple sclerosis	3.45e-05	0.000126	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—POMC—multiple sclerosis	3.27e-05	0.00012	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—APOE—multiple sclerosis	3.18e-05	0.000116	CbGpPWpGaD
L-Arginine—NOS3—Disease—CD4—multiple sclerosis	3.14e-05	0.000115	CbGpPWpGaD
L-Arginine—NOS2—Disease—STAT3—multiple sclerosis	3.13e-05	0.000114	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—ALB—multiple sclerosis	2.98e-05	0.000109	CbGpPWpGaD
L-Arginine—NOS2—Disease—MYC—multiple sclerosis	2.91e-05	0.000106	CbGpPWpGaD
L-Arginine—NOS2—Disease—TGFB1—multiple sclerosis	2.9e-05	0.000106	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CD80—multiple sclerosis	2.88e-05	0.000105	CbGpPWpGaD
L-Arginine—NOS2—Disease—MAPK1—multiple sclerosis	2.84e-05	0.000104	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—POMC—multiple sclerosis	2.73e-05	9.99e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CCL2—multiple sclerosis	2.68e-05	9.78e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—TYK2—multiple sclerosis	2.43e-05	8.88e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—STAT3—multiple sclerosis	2.43e-05	8.88e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—MYC—multiple sclerosis	2.26e-05	8.25e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—TGFB1—multiple sclerosis	2.25e-05	8.23e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—MAPK1—multiple sclerosis	2.21e-05	8.07e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—IL6—multiple sclerosis	2.19e-05	7.99e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—IL2—multiple sclerosis	2.02e-05	7.39e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—MMP9—multiple sclerosis	1.91e-05	6.99e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—STAT3—multiple sclerosis	1.7e-05	6.22e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—IL6—multiple sclerosis	1.7e-05	6.2e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—MYC—multiple sclerosis	1.58e-05	5.78e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—TGFB1—multiple sclerosis	1.58e-05	5.76e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—MAPK1—multiple sclerosis	1.55e-05	5.65e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—IL6—multiple sclerosis	1.19e-05	4.34e-05	CbGpPWpGaD
